UNIVERSAL ACCESS
TO MEDICINES
IN 2022, COVID-19 VACCINES AND HEALTH TECHNOLOGIES WERE STILL FAR FROM BEING ACCESSIBLE TO EVERYONE, DESPITE A WTO AGREEMENT ON PATENT SUSPENSIONS THAT DID NOT ADDRESS GLOBAL PANDEMIC NEEDS. A BIG PART OF OUR WORK DURING THE YEAR WAS ON INTELLECTUAL PROPERTY AND PATENT EXEMPTION - NOT ONLY FOR VACCINES, BUT FOR DIAGNOSTIC TESTING AND TREATMENTS. WE ALSO FOCUSED ON HIPRA'S SPANISH VACCINE, WHICH HAD A SIGNIFICANT PUBLIC INVESTMENT. AND WE TOOK PART IN A NUMBER OF EU CONSULTATION PROCESSES ON INTELLECTUAL PROPERTY AND GLOBAL HEALTH STRATEGY. DURING THE YEAR, WE ALSO PUBLISHED A NUMBER OF REPORTS AND CONTINUED OUR WORK IN INTERNATIONAL ARENAS ON ACCESS TO MEDICINES.